|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bagan J, Sarrion G and Jimenez Y: Oral
cancer: Clinical features. Oral Oncol. 46:414–417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schantz SP and Yu GP: Head and neck cancer
incidence trends in young Americans, 1973–1997, with a special
analysis for tongue cancer. Arch Otolaryngol Head Neck Surg.
128:268–274. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feller LL, Khammissa RR, Kramer BB and
Lemmer JJ: Oral squamous cell carcinoma in relation to field
precancerisation: Pathobiology. Cancer Cell Int. 13:312013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung KW, Won YJ, Oh CM, Kong HJ, Cho H,
Lee JK, Lee DH and Lee KH: Prediction of cancer incidence and
mortality in Korea, 2016. Cancer Res Treat. 48:451–457. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho JH, Lee RH, Jeon YJ, Shin JC, Park SM,
Choi NJ, Seo KS, Yoon G, Cho SS, Kim KH, et al: Role of
transcription factor Sp1 in the 4-O-methylhonokiol-mediated
apoptotic effect on oral squamous cancer cells and xenograft. Int J
Biochem Cell Biol. 64:287–297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harvey AL: Natural products in drug
discovery. Drug Discov Today. 13:894–901. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Watkins R, Wu L, Zhang C, Davis RM and Xu
B: Natural product-based nanomedicine: Recent advances and issues.
Int J Nanomedicine. 10:6055–6074. 2015.PubMed/NCBI
|
|
10
|
Cragg GM and Newman DJ: Plants as a source
of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs over the 30 years from 1981 to 2010. J Nat
Prod. 75:311–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang ZY and Nixon DW: Licorice and cancer.
Nutr Cancer. 39:1–11. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoon G, Jung YD and Cheon SH: Cytotoxic
allyl retrochalcone from the roots of Glycyrrhiza inflata. Chem
Pharm Bull (Tokyo). 53:694–695. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Cao Y, Paudel S, Yoon G and Cheon
SH: Concise synthesis of licochalcone C and its regioisomer,
licochalcone H. Arch Pharm Res. 36:pp. 1432–1436. 2013, View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakamura A, Osonoi T and Terauchi Y:
Relationship between urinary sodium excretion and
pioglitazone-induced edema. J Diabetes Investig. 1:208–211. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeitz MJ, Malyavantham KS, Seifert B and
Berezney R: Matrin 3: Chromosomal distribution and protein
interactions. J Cell Biochem. 108:125–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salton M, Elkon R, Borodina T, Davydov A,
Yaspo ML, Halperin E and Shiloh Y: Matrin 3 binds and stabilizes
mRNA. PLoS One. 6:e238822011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valencia CA, Ju W and Liu R: Matrin 3 is a
Ca2+/calmodulin-binding protein cleaved by caspases.
Biochem Biophys Res Commun. 361:281–286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Przygodzka P, Boncela J and Cierniewski
CS: Matrin 3 as a key regulator of endothelial cell survival. Exp
Cell Res. 317:802–811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coelho MB, Attig J, Bellora N, König J,
Hallegger M, Kayikci M, Eyras E, Ule J and Smith CW: Nuclear matrix
protein Matrin3 regulates alternative splicing and forms
overlapping regulatory networks with PTB. EMBO J. 34:653–668. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chaudhary R, Gryder B, Woods WS,
Subramanian M, Jones MF, Li XL, Jenkins LM, Shabalina SA, Mo M,
Dasso M, et al: Prosurvival long noncoding RNA PINCR regulates a
subset of p53 targets in human colorectal cancer cells by binding
to Matrin 3. Elife. 6(pii): e232442017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Patrycja P, Joanna B and Czeslaw SC:
Matrin 3 as a key regulator of endothelial cell survival. Exp Cell
Res. 317:802–811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoon G, Lee W, Kim SN and Cheon SH:
Inhibitory effect of chalcones and their derivatives from
Glycyrrhiza inflata on protein tyrosine phosphatase 1B. Bioorg Med
Chem Lett. 19:5155–5157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Z, Lee W, Kim SN, Yoon G and Cheon SH:
Design, synthesis, and evaluation of bromo-retrochalcone
derivatives as protein tyrosine phosphatase 1B inhibitors. Bioorg
Med Chem Lett. 21:pp. 3755–3758. 2011, View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schafer KA: The cell cycle: A review. Vet
Pathol. 35:461–478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ilyin GP, Glaise D, Gilot D, Baffet G and
Guguen-Guillouzo C: Regulation and role of p21 and p27
cyclin-dependent kinase inhibitors during hepatocyte
differentiation and growth. Am J Physiol Gastrointest Liver
Physiol. 285:G115–G127. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oh H, Yoon G, Shin JC, Park SM, Cho SS,
Cho JH, Lee MH, Liu K, Cho YS, Chae JI, et al: Licochalcone B
induces apoptosis of human oral squamous cell carcinoma through the
extrinsic- and intrinsic-signaling pathways. Int J Oncol.
48:1749–1757. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhai D, Jin C, Huang Z, Satterthwait AC
and Reed JC: Differential regulation of Bax and Bak by
anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. J Biol Chem.
283:9580–9586. 2008. View Article : Google Scholar : PubMed/NCBI
|
